CLASSEN IMMUNOTHERAPIES v. BIOGEN IDEC

Joseph J. Zito, Zito tip, of Washington, DC, argued for plaintiff-appellant. Joshua M. Hiller, Wilmer Cutler Pickering Hale and Dorr LLP, of Boston, MA, for defendant-appellee, Biogen IDEC. On the brief were David B. Bassett, of New York, NY, and David A. Wilson, of Washington, DC. George F. Pappas, Covington Burling LLP, of Washington, DC, argued for defendant-appellee, GlaxoSmithKline. With him on the brief were Jeffrey B. Elikan and Kevin B. Collins. Of counsel was Scott C. Weidenfeller. Mary B. Graham, Morris, Nichols, Arsht Tunnell, LLP, of Wilmington, DE, argued for defendant-cross appellant. With her on the brief was James W. Parrett, Jr. Of counsel on the brief were Robert L. Baechtold, Fitzpatrick, Cella, Harper Scinto, of New York, NY; and Edward W. Murray and Mary J. Morry, Merck Co., Inc., of Rahway, NJ.